Cargando…

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders

Detalles Bibliográficos
Autores principales:	Villa, Chiara, Paudel, Yam Nath, Piperi, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496768/ https://www.ncbi.nlm.nih.gov/pubmed/36138926 http://dx.doi.org/10.3390/brainsci12091190

Ejemplares similares

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

From the Molecular Mechanism to Pre-clinical Results: Anti-epileptic Effects of Fingolimod
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas
por: Angelopoulou, Efthalia, et al.
Publicado: (2019)

HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases
por: Kaminska, Joanna, et al.
Publicado: (2021)

Ageing and Neurodegenerative Disorders
por: Piccardi, Laura, et al.
Publicado: (2015)

Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases 2.0
por: Kaminska, Joanna, et al.
Publicado: (2022)

Neurodegenerative disease: models, mechanisms, and a new hope
por: Gitler, Aaron D., et al.
Publicado: (2017)

Multimodal MRI in Neurodegenerative Disorders
por: Cerasa, Antonio, et al.
Publicado: (2012)

Chronic Pain: New Insights in Molecular and Cellular Mechanisms
por: Luongo, Livio, et al.
Publicado: (2015)

Psychiatric disorders: neurodevelopmental disorders, neurodegenerative disorders, or both?
por: Thibaut, Florence
Publicado: (2018)

Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders
por: Kim, Yoon-Seong, et al.
Publicado: (2012)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

New Hopes and Challenges for Treatment of Neurodegenerative Disorders: Great Opportunities for Young Neuroscientists
por: Kiaei, Mahmoud
Publicado: (2013)

Copper Status in Alzheimer's Disease and Other Neurodegenerative Disorders: Genetics, Mechanisms, Neurophysiology, and Therapies
por: Squitti, Rosanna, et al.
Publicado: (2011)

Oxidative Stress and Mitochondrial Damage in Neurodegenerative Diseases: From Molecular Mechanisms to Targeted Therapies
por: Cenini, Giovanna, et al.
Publicado: (2020)

Imaging Neurodegenerative Diseases: Mechanisms and Interventions
por: Bai, Lijun, et al.
Publicado: (2014)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

New Insights in Molecular Mechanisms in Antimicrobial Resistance and Strategies in Anti-Biofilms
por: Liu, Junyan, et al.
Publicado: (2023)

Global warming and neurodegenerative disorders: speculations on their linkage
por: Habibi, Laleh, et al.
Publicado: (2014)

SIRT2 in age-related neurodegenerative disorders
por: Fourcade, Stéphane, et al.
Publicado: (2018)

Neurological and Neurodegenerative Disorders: Novel Concepts and Treatment
por: Kirmani, Batool F, et al.
Publicado: (2021)

Neurodegenerative Diseases: From Molecular Basis to Therapy
por: Agnello, Luisa, et al.
Publicado: (2022)

The Molecular Basis for the Environmental Promotion of Neurodegenerative Disease
por: Bondy, Stephen
Publicado: (2023)

Pathogenic Molecular Mechanisms in Periodontitis and Peri-Implantitis: Role of Advanced Glycation End Products
por: Plemmenos, Grigorios, et al.
Publicado: (2022)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

New Insights into Antibacterial Compounds: From Synthesis and Discovery to Molecular Mechanisms of Action
por: Leitão, Jorge H.
Publicado: (2020)

Molecular and Cellular Mechanisms of Corneal Scarring and Advances in Therapy
por: Fuest, Matthias, et al.
Publicado: (2023)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Caregiver Burden in Movement Disorders and Neurodegenerative Diseases: Editorial
por: Klietz, Martin
Publicado: (2022)

Application of Complementary and Alternative Medicine on Neurodegenerative Disorders 2013
por: Ip, Paul Siu-Po, et al.
Publicado: (2014)

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders
por: Cherubini, Enrico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g5dfj57itas75u5hd7inqntpn2